A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
PHASE2
This is a multicenter, open-label Phase IIa clinical study to evaluate the ...
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions
N/A
Immune checkpoint inhibitors and anti-vascular endothelial growth factor an...
Status
Completed
Location
Zhongda Hospital
Start Date
2018-06-01
Trial ID
NCT06881446
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
EARLY_PHASE1
Most pediatric patients with solid tumors respond to initial high-dose, int...